Seizure Detection Using Kaoskey TRIO Software

Not Applicable

• Conditions: Epilepsy; Neurological - Epilepsy

• Registration Number: ACTRN12620000600943
• Lead Sponsor: Kaoskey Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-05-25
• Last Update Posted: 1 June 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Is able to provide personally signed and dated informed consent to participate in the study before completing any study related procedures.
• Male or female (aged 18 years or older).
• Possible diagnosis of epilepsy and admitted for inpatient video-EEG monitoring.

Exclusion Criteria

• History of a cardiac rhythm or conduction disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seizure events as assessed by high-resolution ECG recordings with the TRIO” software and with Alfred Video-EEG to be compared to provide false positive / false negative assessment of TRIO performance versus the current clinical standard.[Data will be collected during the five-day inpatient video-EEG monitoring period.]

Secondary Outcome Measures

Name	Time	Method
The quality of ECG recordings from the compact 2-channel chest-mounted sensor for seizure detection, assessed by sufficient performance of the TRIO software.[Data will be collected during the five-day inpatient video-EEG monitoring period.]